Loading stock data…
$86.88-1.26 (-1.43%)
Merit Medical Systems, Inc.
Merit Medical Systems, Inc. in the Healthcare sector is trading at $86.88 with a market capitalization of $5.4B. Wall Street consensus targets $101.45 (11 analysts), implying a +16.8% move over the next 12 months. The stock is currently 8% below its 52-week high of $94.75, remaining 13.3% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $418.84M↑ | $381.88M↓ | $393.94M↑ | $384.16M↑ | $382.46M |
| Gross Profit | $215.17M↑ | $184.80M↓ | $195.35M↑ | $186.41M↑ | $184.49M |
| Operating Income | $60.55M↑ | $43.98M↓ | $53.98M↑ | $42.64M↓ | $47.02M |
| Net Income | $38.80M↓ | $40.99M↑ | $38.01M↑ | $27.75M↓ | $32.58M |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and international...